Real-World Assessment of Relapse, Medical Costs and Persistency of Multiple Sclerosis Patients Treated With Subcutaneous Interferon β-1a
Phillips, AL, Locklear, JC, Kozma, CVolume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.2928
Date:
November, 2015
File:
PDF, 54 KB
english, 2015